Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010)

International Clinical Psychopharmacology

Volumn 28, Issue 2, 2013, Pages 87-90

  Jing, Yonghua ^a   Guo, Zhenchao ^a   Kalsekar, Iftekhar ^a   Forbes, Robert A ^b   Hebden, Tony ^a   Thase, Michael E ^c  

^a BRISTOL MYERS SQUIBB   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adjunctive therapy; aripiprazole; atypical antipsychotics; dosing pattern; major depressive disorder; quetiapine

Indexed keywords

ARIPIPRAZOLE; QUETIAPINE;

ADULT; ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; DRUG APPROVAL; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUGS, INVESTIGATIONAL; FEMALE; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PIPERAZINES; QUINOLONES; RETROSPECTIVE STUDIES; SPATIO-TEMPORAL ANALYSIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 84873406549     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32835ce232     Document Type: Article

References (6)

1. Cates ME, Jackson CW, Feldman JM, Stimmel AE, Woolley TW (2009). Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients. Community Ment Health J 45:251-254.
2. Deyo RA, Cherkin DC, Ciol MA (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619.
3. Hartung D, Wisdom J, Pollack DA, Hamer A, Haxby D, Middleton L, et al. (2008). Patterns of atypical antipsychotic subtherapeutic dosing among Oregon medicaid patients. J Clin Psychiatry 69:1540-1547.
4. Martinez Gonzalez D, Obermeyer WH, Benca RM (2002). Comorbidity of insomnia with medical and psychiatric disorders. Prim Psychiatry 9:37-49.
5. Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Tran QV, et al. (2009). Safety and tolerability of adjunctive aripiprazole in major depressive disorder: a pooled analysis (studies CN138-139 and CN138-163). Prim Care Companion J Clin Psychiatry 11:344-352.
6. Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H, et al. (2009). Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study. CNS Spectr 14:299-313.